Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Endocrinology
|
September 1, 1984
Metabolism of luteinizing hormone by the pseudopregnant rat ovary
E A Rorke, G T Faircloth, J L Vaitukaitis
Journal of Biological Regulators and Homeostatic Agents
|
November 29, 2002
Changes in gene expression profile induced by the anticancer agent Aplidine in Molt-4 leukemic cell lines
S Marchini, G Chiorino, G T Faircloth, et al.
Endocrinology
|
July 1, 1986
Differential subcellular distribution of bioactive human chorionic gonadotropin in pseudopregnant rat ovary
A Gilligan, H Kawamura, G T Faircloth, et al.
Cancer Chemotherapy and Pharmacology
|
August 14, 1999
Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assays
A A Geldof, S C Mastbergen, R E Henrar, et al.
British Journal of Cancer
|
September 22, 1998
In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells
H Depenbrock, R Peter, G T Faircloth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 13, 2001
Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action
E Erba, D Bergamaschi, L Bassano, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
September 22, 2001
Evaluation of the use of in vitro methodologies as tools for screening new compounds for potential in vivo toxicity
J Luber-Narod, B Smith, W Grant, et al.
Leukemia
|
July 2, 2003
In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development
D Bresters, A J F Broekhuizen, P Kaaijk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 1999
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer
H R Hendriks, H H Fiebig, R Giavazzi, et al.
International Journal of Cancer
|
April 17, 2001
Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways
G Damia, S Silvestri, L Carrassa, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Endocrinology
|
September 1, 1984
Metabolism of luteinizing hormone by the pseudopregnant rat ovary
E A Rorke, G T Faircloth, J L Vaitukaitis
Journal of Biological Regulators and Homeostatic Agents
|
November 29, 2002
Changes in gene expression profile induced by the anticancer agent Aplidine in Molt-4 leukemic cell lines
S Marchini, G Chiorino, G T Faircloth, et al.
Endocrinology
|
July 1, 1986
Differential subcellular distribution of bioactive human chorionic gonadotropin in pseudopregnant rat ovary
A Gilligan, H Kawamura, G T Faircloth, et al.
Cancer Chemotherapy and Pharmacology
|
August 14, 1999
Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assays
A A Geldof, S C Mastbergen, R E Henrar, et al.
British Journal of Cancer
|
September 22, 1998
In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells
H Depenbrock, R Peter, G T Faircloth, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 13, 2001
Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action
E Erba, D Bergamaschi, L Bassano, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
September 22, 2001
Evaluation of the use of in vitro methodologies as tools for screening new compounds for potential in vivo toxicity
J Luber-Narod, B Smith, W Grant, et al.
Leukemia
|
July 2, 2003
In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development
D Bresters, A J F Broekhuizen, P Kaaijk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 1999
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer
H R Hendriks, H H Fiebig, R Giavazzi, et al.
International Journal of Cancer
|
April 17, 2001
Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways
G Damia, S Silvestri, L Carrassa, et al.
Page
of 2